Diagnosis, Testing, and Lifestyle Management of Hypertriglyceridemia

Description

Learner Objectives

Upon completion of this activity, you should be able to:

Identify the relevant tests for Hypertriglyceridemia (HTG), including genetic conditions like Familial Chylomicronemia Syndrome (FCS), and apply current treatment guidelines and consensus statement recommendations.
Implement lifestyle modifications, including dietary changes and regular physical activity, to improve patient’s lipid profiles.

Planning Committee

Michael Miller, MD, FACC

University of Pennsylvania

Disclosure

Consulting Fees/Honoraria: Amarin, Ionis Pharmaceuticals, New Amsterdam Pharmaceuticals, & Novo Nordisk Inc.

Chris Owen, MS, APRN, ACNP-BC, RNFA, FACC

American College of Cardiology
Disclosure
Consultant Fees/Honoraria: SilkRoad

Faculty

Archna Bajaj, MD
University of Pennsylvania

Disclosure

Research/Research Grants: Amgen Inc, Arrowhead, Eli Lilly and Company, Ionis Pharmaceuticals, NewAmsterdam Pharma, Novartis Corporation
Speaker’s Bureau: Arrowhead, Ionis Pharmaceuticals

Grant Acknowledgement
Educational grant support for this activity provided by Ionis Pharmaceuticals.

Summary

Availability:

On-Demand

Access expires on Mar 31, 2028

Cost:

FREE

Credit Offered:

0.5 CME Credit

0.5 CNE Credit

0.5 AAPA Credit

0.5 ABIM-MOC Point

0.5 IPCE Credit